Literature DB >> 21946892

Diabetes: T2DM-PPARγ ligands without the adverse effects?

Carol Wilson.   

Abstract

Entities:  

Year:  2011        PMID： 21946892     DOI： 10.1038/nrendo.2011.167

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  1 in total

1.  Antidiabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylation.

Authors:  Jang Hyun Choi; Alexander S Banks; Theodore M Kamenecka; Scott A Busby; Michael J Chalmers; Naresh Kumar; Dana S Kuruvilla; Youseung Shin; Yuanjun He; John B Bruning; David P Marciano; Michael D Cameron; Dina Laznik; Michael J Jurczak; Stephan C Schürer; Dušica Vidović; Gerald I Shulman; Bruce M Spiegelman; Patrick R Griffin
Journal:  Nature       Date:  2011-09-04       Impact factor: 49.962
  1 in total
  1 in total

Review 1.  Antidiabetic Properties of Curcumin: Insights on New Mechanisms.

Authors:  Elahe Mohammadi; Behzad Behnam; Reza Mohammadinejad; Paul C Guest; Luis E Simental-Mendía; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.